CN Patent

CN108743567A — 氢溴酸加兰他敏口溶膜剂及其制备方法

Assigned to Taiyangsheng Bozhou Biomedical Technology Co ltd · Expires 2018-11-06 · 8y expired

What this patent protects

本发明实施例提供了一种氢溴酸加兰他敏口溶膜剂及其制备方法，属于药物制剂领域，能够解决现有氢溴酸加兰他敏药物剂型服用不便的问题。所述氢溴酸加兰他敏口溶膜剂包括：5‑30wt％的氢溴酸加兰他敏、20‑70wt％的水溶性成膜剂、1‑10wt％的增塑剂、10‑30wt％的崩解剂和1‑15wt％的矫味剂。所述氢溴酸加兰他敏口溶膜剂可用于治疗阿尔茨海默病。

USPTO Abstract

本发明实施例提供了一种氢溴酸加兰他敏口溶膜剂及其制备方法，属于药物制剂领域，能够解决现有氢溴酸加兰他敏药物剂型服用不便的问题。所述氢溴酸加兰他敏口溶膜剂包括：5‑30wt％的氢溴酸加兰他敏、20‑70wt％的水溶性成膜剂、1‑10wt％的增塑剂、10‑30wt％的崩解剂和1‑15wt％的矫味剂。所述氢溴酸加兰他敏口溶膜剂可用于治疗阿尔茨海默病。

Drugs covered by this patent

Patent Metadata

Patent number
CN108743567A
Jurisdiction
CN
Classification
—
Expires
2018-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Taiyangsheng Bozhou Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.